跳到正文
原文
Medical Xpress·· 28 天前AI 评分55

ROCKY 标准化肾脏活检路径在高危患者中严重并发症率为 0.8%

Standardized kidney biopsy protocol is safe in high-risk patients

AI 导读

一项前瞻性研究显示,采用 ROCKY 标准化肾脏活检路径的 1096 例高危患者中,严重并发症发生率为 0.8%,未出现肾脏切除或操作相关死亡。该结果在 ASN Kidney Week 2026 公布,住院与门诊操作的严重并发症率无显著差异。高龄、肾功能受损以及抗血小板或抗凝治疗等传统高危因素,与严重并发症无独立关联,所有操作的诊断准确性均达成。

正文
biopsy
Credit: Unsplash/CC0 Public Domain

Results from a prospective study reveal that with standardized precautions, even high-risk patients may safely undergo a kidney biopsy, a cornerstone of kidney diagnostics that is often perceived as dangerous in certain vulnerable patient populations. The findings were presented at ASN Kidney Week 2026, Oct. 22–25.

The research involved the use of the ROCKY standardized protocol (Renal-biopsy Optimized Care and Knowledge Yielding safety), which combines structured checkpoints to maximize the diagnostic utility of a kidney biopsy while minimizing its associated risks, such as bleeding.

Among 1,096 kidney biopsies performed on patients with predefined high-risk features, the ROCKY standardized protocol was associated with a low rate of severe complications (0.8%), with no kidney removals or procedure-related deaths. Severe complication rates were not significantly different between inpatient and outpatient procedures.

Furthermore, traditional factors that are considered high risk—including older age, impaired kidney function and antiplatelet or anticoagulant therapy—were not independently associated with severe complications. Diagnostic accuracy was achieved in all procedures.

"Kidney biopsy can be performed safely even in patients traditionally considered at increased procedural risk when undertaken within a rigorous, standardized pathway incorporating structured prebiopsy assessment, risk-factor correction, ultrasound-guided biopsy and systematic postprocedure monitoring," said corresponding author Dario Roccatello, M.D., Ph.D., of the University of Turin in Italy.

"Our findings may broaden access to kidney biopsy for patients who might otherwise be denied an important diagnostic and prognostic procedure because of age, kidney impairment, obesity, antithrombotic treatment, dialysis or anatomical abnormalities. In addition, the comparable safety observed in outpatients supports expansion of outpatient biopsy programs with the potential to reduce unnecessary hospitalization and improve health care resource utilization."

More information

Prospective Validation of the ROCKY Protocol for High-Risk Kidney Biopsy in 1,000 Procedures over 10 Years, ASN Kidney Week 2026

Key medical concepts

Kidney Biopsy

Clinical categories

Nephrology

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Standardized kidney biopsy protocol is safe in high-risk patients (2026, October 22) retrieved 22 October 2026 from https://medicalxpress.com/news/2026-10-standardized-kidney-biopsy-protocol-safe.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com